Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.
about
Immunological cells and functions in Gaucher diseaseCytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccinesCan immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?A global approach to HIV-1 vaccine developmentIdentification of a cluster of HIV-1 controllers infected with low replicating virusesIntact dendritic cell pathogen-recognition receptor functions associate with chronic hepatitis C treatment-induced viral clearanceInhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressorsRegulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirsToward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen TypesRelationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patientsHLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.Comprehensive analysis of unique cases with extraordinary control over HIV replication.MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys.Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells.APOBEC3 proteins can copackage and comutate HIV-1 genomes.Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).A real-time killing assay to follow viral epitope presentation to CD8 T cellsEvolution of an attenuated HIV-1 isolate in an elite suppressor.A cure for HIV: is it in sight?Success and failure of the cellular immune response against HIV-1.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.Impaired Nef function is associated with early control of HIV-1 viremia.Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.
P2860
Q26827675-98B65988-AA05-4685-8A2C-A0710F0EC358Q26827712-16784E91-8EC9-4EE3-B111-48E1BA7A85C8Q26865388-0C9A31F3-57D2-471F-9529-B3F3C5C1D546Q27024614-DF7D9775-2B67-422E-9739-33365AD8A14DQ28534737-B3F12B70-8438-4C77-B998-68AECC4D27F2Q28540848-7382AA82-3391-4E5D-9C0C-61E93662C087Q28710569-4B0BEDA2-00F4-444E-927A-2726D527859AQ31158755-F0122A0D-4154-4DB6-8ADA-285994A8C11AQ34066815-F8A3C0F4-7786-401B-9802-E407BB87C8C0Q34950830-D5F7A1FE-AD7C-4125-B46E-8D9703C8C607Q35021753-AE9AD6C7-EB3A-40D4-9E25-5D2845AE753AQ35216907-FC4FF303-3DF7-4BF1-954A-B267F9A3D169Q35661912-B94305E6-31D0-45D2-ACA4-D28BA20749DCQ35797743-C570B1A4-03F8-49CD-8E55-BA1B928195D9Q35799435-34661F71-703B-4EA7-A336-BE90B8E2DA1CQ35826897-A4DA4DCB-9BCE-421B-A9E1-E3B6F43554D3Q35826902-E1CABD7A-DE51-4D79-AED3-C2EEC5FB78B0Q35883750-DAF78851-AB6F-4BE1-817C-25923F7BC435Q35886963-FDDEF2B7-1880-4A99-8EB8-9B5CAFAF11FFQ36010191-DBDADDF0-25EC-4EE3-A79D-1F97FA94FF61Q36015292-D7AD6F25-0BCD-49B1-9790-0B39C025350BQ36086229-9B4B9C20-BF58-49E8-BCE8-C2DDB22E3E1BQ36208223-3970F7E6-1EA5-406A-BB4E-35E55B30B888Q36246220-D10FB6E9-5C4E-441A-A697-A1C948257E69Q36409885-2BC54F3C-3461-4762-AE69-1A32DFC15EA2Q36601983-8C6F7763-26DC-426A-81F9-3CA3344284B0Q36694851-2FCE6094-4AC8-4F11-9B3A-CEB33FB2E0ADQ37264399-2FD15B21-0161-4D8F-B14D-D97B92F0BAA5Q37312736-7DD3C9C5-DB22-4CAB-80EC-09E054C40B4AQ37352748-C53AE88B-E56E-468C-A95D-B5CD45340354Q37610618-4235D1A7-6DE8-4F58-91DB-0E0598C4D5F1Q38205472-CFA75BF8-4B1C-4E1A-9217-92C586F23E3CQ38491191-15D4512D-A509-49C7-8283-8A66AF7D60D9Q40142539-50D3C5CC-A909-419A-B88A-994634D4F3EBQ40159913-322482A6-16CF-4B8D-911F-5AD8FB86252FQ40633369-32DC6488-8EA8-47D8-B084-606C4F45E282Q41762711-7CDBB4C4-6134-406B-9A55-FFD7165DFF13Q41916926-FB08865F-94FE-403C-965E-BF93481FDEEDQ42208915-2B45296C-991F-46A8-B234-82D69AA43B72Q42253119-334A6572-DDC4-453C-B44B-3AC6866C62D8
P2860
Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Qualitative features of the HI ...... ated with immunologic control.
@ast
Qualitative features of the HI ...... ated with immunologic control.
@en
type
label
Qualitative features of the HI ...... ated with immunologic control.
@ast
Qualitative features of the HI ...... ated with immunologic control.
@en
prefLabel
Qualitative features of the HI ...... ated with immunologic control.
@ast
Qualitative features of the HI ...... ated with immunologic control.
@en
P2093
P2860
P1476
Qualitative features of the HI ...... ated with immunologic control.
@en
P2093
Adam R Hersperger
Mark Connors
Michael R Betts
Stephen A Migueles
P2860
P304
P356
10.1097/COH.0B013E3283454C39
P577
2011-05-01T00:00:00Z